Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Guizhou Utide Biotechnology Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1AOD9604

    02 1Bpc-157

    03 1CJC1295

    04 1Cagrilintide

    05 1Linaclotide

    06 1Mazdutide

    07 1Retatrutide API

    08 1Semaglutide

    09 1Sermorelin

    10 1Survodutide

    11 1Teduglutide

    12 1Tesamorelin

    13 1Tirzepatide

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      AOD9604

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
      Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
      blank

      01

      AOD9604

      China
      VMX
      Not Confirmed
      arrow

      AOD9604

      China
      arrow
      VMX
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Guizhou Utide Biotechnology Co., Ltd

      Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

      About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

      blank

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Bpc-157

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
        Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
        blank

        02

        Bpc-157

        China
        VMX
        Not Confirmed
        arrow

        Bpc-157

        China
        arrow
        VMX
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Guizhou Utide Biotechnology Co., Ltd

        Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

        About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

        blank

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Cagrilintide

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
          Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
          blank

          03

          Cagrilintide

          China
          VMX
          Not Confirmed
          arrow

          Cagrilintide

          China
          arrow
          VMX
          Not Confirmed
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Guizhou Utide Biotechnology Co., Ltd

          Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

          About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

          blank

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
            Post an Enquiry Post an Enquiry
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CJC1295

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
            Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
            blank

            04

            CJC1295

            China
            VMX
            Not Confirmed
            arrow

            CJC1295

            China
            arrow
            VMX
            Not Confirmed
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
            Post an Enquiry Post an Enquiry
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Guizhou Utide Biotechnology Co., Ltd

            Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

            About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

            blank

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
              Post an Enquiry Post an Enquiry
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Linaclotide

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
              Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
              blank

              05

              Linaclotide

              China
              VMX
              Not Confirmed
              arrow

              Linaclotide

              China
              arrow
              VMX
              Not Confirmed
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
              Post an Enquiry Post an Enquiry
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Guizhou Utide Biotechnology Co., Ltd

              Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

              About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

              blank

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                Post an Enquiry Post an Enquiry
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Mazdutide

                Product
                Web Link

                Stock Recap
                #PipelineProspector

                Market
                Place

                Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
                Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
                blank

                06

                Mazdutide

                China
                VMX
                Not Confirmed
                arrow

                Mazdutide

                China
                arrow
                VMX
                Not Confirmed
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                Post an Enquiry Post an Enquiry
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Guizhou Utide Biotechnology Co., Ltd

                Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

                About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

                blank

                Product
                Web Link

                Stock Recap
                #Pipeline Prospector

                Market
                Place

                Contact Supplier
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                  Post an Enquiry Post an Enquiry
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Retatrutide API

                  Product
                  Web Link

                  Stock Recap
                  #PipelineProspector

                  Market
                  Place

                  Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
                  Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
                  blank

                  07

                  Retatrutide API

                  China
                  VMX
                  Not Confirmed
                  arrow

                  Retatrutide API

                  China
                  arrow
                  VMX
                  Not Confirmed
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                  Post an Enquiry Post an Enquiry
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Guizhou Utide Biotechnology Co., Ltd

                  Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

                  About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

                  blank

                  Product
                  Web Link

                  Stock Recap
                  #Pipeline Prospector

                  Market
                  Place

                  Contact Supplier
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                    Post an Enquiry Post an Enquiry
                    Flag China
                    Virtual Booth Virtual Booth
                    Digital Content Digital Content

                    Semaglutide

                    Product
                    Web Link

                    Stock Recap
                    #PipelineProspector

                    Market
                    Place

                    Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
                    Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
                    blank

                    08

                    Semaglutide

                    China
                    VMX
                    Not Confirmed
                    arrow

                    Semaglutide

                    China
                    arrow
                    VMX
                    Not Confirmed
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                    Post an Enquiry Post an Enquiry
                    Flag China
                    Virtual Booth Virtual Booth
                    Digital Content Digital Content

                    Guizhou Utide Biotechnology Co., Ltd

                    Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

                    About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

                    blank

                    Product
                    Web Link

                    Stock Recap
                    #Pipeline Prospector

                    Market
                    Place

                    Contact Supplier
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                      Post an Enquiry Post an Enquiry
                      Flag China
                      Virtual Booth Virtual Booth
                      Digital Content Digital Content

                      Sermorelin

                      Product
                      Web Link

                      Stock Recap
                      #PipelineProspector

                      Market
                      Place

                      Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
                      Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
                      blank

                      09

                      Sermorelin

                      China
                      VMX
                      Not Confirmed
                      arrow

                      Sermorelin

                      China
                      arrow
                      VMX
                      Not Confirmed
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                      Post an Enquiry Post an Enquiry
                      Flag China
                      Virtual Booth Virtual Booth
                      Digital Content Digital Content

                      Guizhou Utide Biotechnology Co., Ltd

                      Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

                      About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

                      blank

                      Product
                      Web Link

                      Stock Recap
                      #Pipeline Prospector

                      Market
                      Place

                      Contact Supplier
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                        Post an Enquiry Post an Enquiry
                        Flag China
                        Virtual Booth Virtual Booth
                        Digital Content Digital Content

                        Survodutide

                        Product
                        Web Link

                        Stock Recap
                        #PipelineProspector

                        Market
                        Place

                        Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underw...
                        Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.
                        blank

                        10

                        Survodutide

                        China
                        VMX
                        Not Confirmed
                        arrow

                        Survodutide

                        China
                        arrow
                        VMX
                        Not Confirmed
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                        Post an Enquiry Post an Enquiry
                        Flag China
                        Virtual Booth Virtual Booth
                        Digital Content Digital Content

                        Guizhou Utide Biotechnology Co., Ltd

                        Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.

                        About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in pep...

                        blank

                        Product
                        Web Link

                        Stock Recap
                        #Pipeline Prospector

                        Market
                        Place

                        Contact Guizhou Utide Biotechnology Co., Ltd and get a quotation

                        Guizhou Utide Biotechnology Co., Ltd is a supplier offers 13 products (APIs, Excipients or Intermediates).

                        Find a price of AOD 9604 bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Bpc-157 bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Cagrilintide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Linaclotide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Mazdutide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Retatrutide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Semaglutide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Sermorelin Acetate bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Survodutide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Teduglutide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Tesamorelin Acetate bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Tirzepatide bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        Find a price of Unii-62RC32V9N7 bulk offered by Guizhou Utide Biotechnology Co., Ltd

                        • Privacy policy
                        • Terms and conditions
                        • Disclaimers
                        • LinkedIn
                        • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.